ENTRY       D01965                      Drug
NAME        Silodosin (JP18/INN);
            KMD 3213;
            Rapaflo (TN);
            Urief (TN)
PRODUCT     RAPAFLO (Allergan)
  GENERIC   SILODOSIN (Ajanta Pharma USA)
            SILODOSIN (Alembic Pharmaceuticals Limited)
            SILODOSIN (Alembic Pharmaceuticals)
            SILODOSIN (Amneal Pharmaceuticals NY LLC)
            SILODOSIN (Amneal Pharmaceuticals NY LLC)
            SILODOSIN (Aurobindo Pharma Limited)
            SILODOSIN (AvKARE)
            SILODOSIN (Camber Pharmaceuticals)
            SILODOSIN (Lupin Pharmaceuticals)
            SILODOSIN (MSN LABORATORIES PRIVATE LIMITED)
            SILODOSIN (Macleods Pharmaceuticals Limited)
            SILODOSIN (Novadoz Pharmaceuticals LLC)
            SILODOSIN (PD-Rx Pharmaceuticals)
            SILODOSIN (PD-Rx Pharmaceuticals)
            SILODOSIN (Sandoz)
FORMULA     C25H32F3N3O4
EXACT_MASS  495.2345
MOL_WEIGHT  495.5345
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01465  alpha-Adrenergic receptor antagonist
               DG01457  alpha1-Adrenergic receptor antagonist
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02924  UGT substrate
REMARK      Therapeutic category: 2590
            ATC code: G04CA04
            Product: D01965<JP/US>
EFFICACY    Antidysuria, alpha1-Adrenergic receptor antagonist
TARGET      ADRA1A [HSA:148] [KO:K04135]
  PATHWAY   hsa04022(148)  cGMP-PKG signaling pathway
            hsa04080(148)  Neuroactive ligand-receptor interaction
            hsa04270(148)  Vascular smooth muscle contraction
METABOLISM  Enzyme: CYP3A4 [HSA:1576], UGT [KO:K00699]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G04 UROLOGICALS
               G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
                G04CA Alpha-adrenoreceptor antagonists
                 G04CA04 Silodosin
                  D01965  Silodosin (JP18/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genitourinary Agents
              Benign Prostatic Hypertrophy Agents
               Silodosin
                D01965  Silodosin (JP18/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              25  Urogenital and anal organ agents
               259  Miscellaneous
                2590  Miscellaneous
                 D01965  Silodosin (JP18/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01457  alpha1-Adrenergic receptor antagonist
                 D01965  Silodosin
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D01965  Silodosin
              DG02924  UGT substrate
               D01965  Silodosin
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1A
                 D01965  Silodosin (JP18/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01965  Silodosin
              D01965  Silodosin tablets
              D01965  Silodosin orally disintegrating tablets
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01965
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01965
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01965
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01965
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01965
DBLINKS     CAS: 160970-54-7
            PubChem: 7849027
            LigandBox: D01965
ATOM        35
            1   C8y C    25.3627  -16.7293
            2   C8x C    25.3627  -18.1293
            3   C8y C    26.5750  -18.8293
            4   C8y C    27.7875  -18.1293
            5   C8y C    27.7875  -16.7293
            6   C8x C    26.5750  -16.0294
            7   N1y N    29.1189  -18.5619
            8   C1x C    29.9418  -17.4293
            9   C1x C    29.1189  -16.2967
            10  C1b C    29.5453  -19.8751
            11  C1b C    30.9269  -20.1692
            12  C1b C    31.3587  -21.4994
            13  O1a O    32.7377  -21.7931
            14  C5a C    26.5750  -20.2312
            15  N1a N    25.3646  -20.9301
            16  O5a O    27.7896  -20.9325
            17  C1b C    24.1519  -16.0310
            18  C1c C    22.9393  -16.7310
            19  N1b N    21.7269  -16.0310
            20  C1b C    20.5143  -16.7310
            21  C1b C    19.3018  -16.0310
            22  O2a O    18.0893  -16.7310
            23  C8y C    16.8768  -16.0310
            24  C1a C    22.9375  -18.1311
            25  C8y C    16.8768  -14.6309
            26  C8x C    15.6643  -13.9309
            27  C8x C    14.4518  -14.6309
            28  C8x C    14.4518  -16.0310
            29  C8x C    15.6643  -16.7310
            30  O2a O    18.0846  -13.9336
            31  C1b C    19.2952  -14.6325
            32  C1d C    20.5100  -13.9312
            33  X   F    20.5106  -12.5306
            34  X   F    21.7226  -14.6316
            35  X   F    21.7240  -13.2307
BOND        37
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    5   9 1
            11    7  10 1
            12   10  11 1
            13   11  12 1
            14   12  13 1
            15    3  14 1
            16   14  15 1
            17   14  16 2
            18    1  17 1
            19   17  18 1
            20   18  19 1
            21   19  20 1
            22   20  21 1
            23   21  22 1
            24   22  23 1
            25   18  24 1 #Up
            26   23  25 2
            27   25  26 1
            28   26  27 2
            29   27  28 1
            30   28  29 2
            31   23  29 1
            32   25  30 1
            33   30  31 1
            34   31  32 1
            35   32  33 1
            36   32  34 1
            37   32  35 1
///
